OUTbio San Diego Celebrates First Anniversary: A Year of Empowerment and Inclusion for LGBTQ+ Life Science Professionals in San Diego [Yahoo! Finance]
Travere Therapeutics, Inc. (TVTX)
Company Research
Source: Yahoo! Finance
Founded on April 4, 2023 , the organization's mission is to empower LGBTQ+ professionals and allies in life science by fostering an inclusive community where diversity is celebrated. "In the last year, OUTbio San Diego focused on nurturing the vibrant LGBTQ+ life science community in our region, providing a welcoming space for professionals to come together, connect, and thrive," said Tyler Brown , Chair of OUTbio San Diego's Board of Directors. "Membership has reached a new milestone of over 400 life science professionals from more than 250 companies, and growth is showing no signs of slowing." OUTbio San Diego's first event in May 2023 drew over 200 life science professionals and local leaders, including San Diego Mayor Todd Gloria . Elected in 2020, Mayor Gloria is San Diego's first openly gay mayor and first mayor of color. "I was honored to be part of OUTbio San Diego's inaugural event, and I'm thrilled to witness the incredible growth and impact the organization achieved in
Show less
Read more
Impact Snapshot
Event Time:
TVTX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
TVTX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
TVTX alerts
High impacting Travere Therapeutics, Inc. news events
Weekly update
A roundup of the hottest topics
TVTX
News
- Travere Therapeutics, Inc. (NASDAQ: TVTX) had its price target raised by analysts at HC Wainwright from $17.00 to $19.00. They now have a "buy" rating on the stock.MarketBeat
- Travere Therapeutics and CSL Vifor Announce European Commission Approves FILSPARI® (sparsentan) for the treatment of IgA NephropathyGlobeNewswire
- CSL Vifor and Travere Therapeutics Announce European Commission approves FILSPARI® (sparsentan) for the treatment of IgA NephropathyPR Web
- CSL Vifor and Travere Therapeutics Announce European Commission approves FILSPARI® (sparsentan) for the treatment of IgA Nephropathy [Yahoo! Finance]Yahoo! Finance
- CSL Vifor and Travere Therapeutics Announce European Commission approves FILSPARI® (sparsentan) for the treatment of IgA NephropathyPR Newswire
TVTX
Earnings
- 2/15/24 - Beat
TVTX
Sec Filings
- 4/24/24 - Form 8-K
- 4/12/24 - Form 4
- 3/27/24 - Form ARS
- TVTX's page on the SEC website